SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    A. Nosbaum, P. Pralong, A. Rozieres, Y. Dargaud, J.-F. Nicolas, F. Bérard, Hypersensibilité retardée aux héparines : diagnostic et prise en charge thérapeutique, Annales de Dermatologie et de Vénéréologie, 2012, 139, 5, 363

    CrossRef

  2. 2
    Tobias Weberschock, Anna Christina Meister, Kevin Bohrt, Jochen Schmitt, Wolf-Henning Boehncke, Ralf J. Ludwig, The risk for cross-reactions after a cutaneous delayed-type hypersensitivity reaction to heparin preparations is independent of their molecular weight: a systematic review, Contact Dermatitis, 2011, 65, 4
  3. 3
    D. Thuillier, G. Chaby, A. Dadban, E. Dascotte, O. Miquel-Christophe, M. Andrejak, D. Chatelain, C. Lok, Dermatose bulleuse hémorragique associée à une réaction d’hypersensibilité retardée sous héparine de bas poids moléculaire, Annales de Dermatologie et de Vénéréologie, 2009, 136, 10, 705

    CrossRef

  4. 4
    Meyler’s Side Effects of Cardiovascular Drugs, 2009,

    CrossRef

  5. 5
    Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions, 2006,

    CrossRef

  6. 6
    Maria Maroto-Iitani, Yuko Higaki, Makoto Kawashima, Cutaneous allergic reaction to heparins: subcutaneous but not intravenous provocation, Contact Dermatitis, 2005, 52, 4
  7. 7
    Annick Barbaud, Drug patch testing in systemic cutaneous drug allergy, Toxicology, 2005, 209, 2, 209

    CrossRef

  8. 8
    J. E. Borch, C. Bindslev-Jensen, Delayed-type hypersensitivity to heparins, Allergy, 2004, 59, 1
  9. 9
    David L. Hepner, Mariana C. Castells, Anaphylaxis During the Perioperative Period, Anesthesia & Analgesia, 2003, 1381

    CrossRef

  10. 10
    S Amarger, M.-C Ferrier-Le-Bouëdec, S Mansard, P Souteyrand, M D’Incan, Les réactions cutanées d’hypersensibilité retardée aux héparines et héparinoïdes. Aspects cliniques, intérêts et modalités des tests, évolutivité, Revue Française d'Allergologie et d'Immunologie Clinique, 2003, 43, 3, 170

    CrossRef

  11. 11
    Stacey A. Funt, Alberto Hidalgo, David M. Panicek, Subcutaneous Nodules at the Injection Site of Low–Molecular-Weight Heparin: A Mimic of Metastatic Disease at CT, Journal of Computer Assisted Tomography, 2002, 26, 4, 520

    CrossRef

  12. 12
    Annick Barbaud, Margarida Gonçalo, Derk Bruynzeel, Andreas Bircher, Guidelines for performing skin tests withdrugs in the investigation of cutaneous adverse drug reactions, Contact Dermatitis, 2001, 45, 6
  13. 13
    Diana P. Ruiz Genao, Tatiana Sanz SáNchez, Javier SáNchez PéRez, Jesús Fernández Herrera, Amaro García Díez, Placas eritematosas por heparina de bajo peso molecular, Actas Dermo-Sifiliográficas, 2001, 92, 3, 93

    CrossRef

  14. 14
    J. Méndez, M. E. Sanchis, R. Fuente, R. Stolle, J. M. Vega, C. Martinez, A. Armentia, P. Sánchez, A. Fernández, Delayed-type hypersensitivity to subcutaneous enoxaparin, Allergy, 1998, 53, 10
  15. 15
    Barbaud, Reichert-Penetrat, TRÉchot, Jacquin-Petit, Ehlinger, Noirez, Faure, Schmutz, BÉNÉ, The use of skin testing in the investigation of cutaneous adverse drug reactions, British Journal of Dermatology, 1998, 139, 1
    Direct Link:
  16. 16
    P. Wessel, F. Grégoire, F. Wessel, L'allergie immédiate à l'héparine par voie sous-cutanée : réflexions à propos d'un cas, Revue Française d'Allergologie et d'Immunologie Clinique, 1996, 36, 7, 796

    CrossRef

  17. 17
    &NA;, Nadroparin calcium, Reactions Weekly, 1996, &NA;, 589, 10

    CrossRef